Log In
Print this Print this

ARN-927, GDC-0927, RG6047

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionSelective estrogen receptor degrader
Molecular Target Estrogen receptor 1 (ESR1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationBreast cancer
Indication DetailsTreat ER positive and HER2 negative breast cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today